Large numbers of small molecules (“fragments”) were screened for potential use in drug compounds to treat patients who become sick as a result of SARS-CoV-2 infection. The effort involved computational methods and crystallography at the ALS. https://als.lbl.gov/sifting-through-fragments-for-covid-19-treatments/
January 2019 – July 2022
